Werewolf Therapeutics
HOWL----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Werewolf Therapeutics(HOWL) predict that the EBIT is -13.27 M (+26.24%), Beat estimate;the EPS is -0.28 (+30%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B26.24%
-0.01B19.88%
+0.00B6.36%
EPSExceed expectations
-0.2830.00%
-0.29526.25%
+0.01503.75%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf